Company Filing History:
Years Active: 2010-2015
Title: Juan Jose Lasarte Sagastibelza: Pioneering Innovations in Biomedical Science
Introduction
Juan Jose Lasarte Sagastibelza is an accomplished inventor based in Navarra, Spain. He has made significant contributions to the field of biomedical science, particularly in the development of immunostimulatory agents and treatments for diseases related to excessive cytokine expression. With two patents to his name, his work showcases the impact of innovative approaches in healthcare.
Latest Patents
1. **Agents and methods based on the use of the EDA domain of fibronectin**
This invention focuses on the use of a polypeptide derived from the EDA domain of fibronectin. The polypeptide can produce immunostimulatory agents that bind to TLR4 (Toll-like receptor 4). The scope of this invention also includes alternative fragments of the EDA domain that exhibit homology with natural fragments. Production methods and applications of these agents highlight the potential they hold in advancing immune responses.
2. **Peptides with the capacity to bind to transforming growth factor β1 (TGF-β1)**
The second patent details peptides capable of binding to TGF-β1, acting as potential inhibitors of this cytokine's biological activity. These peptides could be instrumental in treating diseases driven by excessive or deregulated expression of TGF-β1, providing a new therapeutic avenue for managing related pathological conditions.
Career Highlights
Juan Jose Lasarte Sagastibelza is currently associated with Proyecto de Biomedicina Cima, S.L., where he continues to innovate in the field of biomedicine. His contributions are recognized for their originality and potential impact on medical therapies, marking him as a valuable asset in the scientific community.
Collaborations
Lasarte has collaborated with notable professionals such as Jesus Prieto Valtuena and Claude Leclerc. Their shared expertise and teamwork have likely enriched the research landscape, advancing projects that address critical health challenges.
Conclusion
In summary, Juan Jose Lasarte Sagastibelza stands out as a prominent inventor in the biomedical realm. His innovative patents not only demonstrate his commitment to scientific advancement but also reflect a promising future in medical treatment options. As he continues to work alongside esteemed colleagues, the potential for collaborative breakthroughs remains high, paving the way for emerging therapies that could revolutionize patient care.